Experts Weigh in on MBC Subtypes: Hormone Receptor-Positive MBC
Doctors define different types (subtypes) of MBC depending on whether cancer has or does not have three markers—estrogen receptor (ER), progesterone receptor...
Read MoreAdvice From the Experts
There is a lot of advice online about stage 4 (or metastatic) breast cancer. Each month we round up advice from the top cancer experts and researchers on a specific topic in metastatic breast cancer research and care.
The topics we have covered include What is CAR-T Therapy?, Lobular Metastatic Breast Cancer and Diagnosing & Treating Bone Metastases and the many other topics listed below.
PAST ARTICLES
2025
- Getting a Second Opinion About Your MBC
- Side Effects of MBC Treatments: Heart Problems
- Side Effects of MBC Treatments: Infection
- Side Effects of MBC Treatments: Sleep Problems and Mental Health
- Side Effects of MBC Treatments: Hair Loss and Body Image
- Side Effects of MBC Treatments: Lymphedema
- Side Effects of MBC Treatments: Brain Fog and Cognitive Problems
- Side Effects of MBC Treatments: Pain and Neuropathy
- Side Effects of MBC Treatments: Fatigue
2024
- Side Effects of MBC Treatments: Digestive System Side Effects
- Different Types of Imaging Scans: Ultrasound Scans
- Different Types of Imaging Scans: Bone Scans
- Different Types of Imaging Scans: PET/CT Scans
- Different Types of Imaging Scans: MRI
- Update: New Biomarkers Can Now be Used to Select Treatment for MBC
- Managing Symptoms When MBC Spreads to the Bones
- Managing Side Effects of ADCs
- What is “Drug Sequencing”?
- Experts Break Down Important MBC Research from SABCS 2023
2023
- What’s the Difference Between Targeted Therapy and Chemotherapy?
- Leaving a Legacy and Hope: Tissue Donation After Death
- The Latest Research on Inflammatory Breast Cancer
- How is ER Low Used in Clinical Trials?
- Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- What are Clinical Practice Guidelines and How are They Developed?
- ASCO Experts Update Guidance for Sacituzumab Govitecan (Trodelvy®) for HR+, HER2- MBC
- What is Stable Disease and How is it Monitored?
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- Breast Cancer Lung Metastasis: Highlighting the Experts
- Breast Cancer Liver Metastasis: Highlighting the Experts
- Breast Cancer Bone Metastasis: Highlighting the Experts
- Breast Cancer Brain Metastasis: Highlighting the Experts
- Why Do Some People Have an Exceptional Response When Being Treated for MBC?
- Why Does The Same Drug Work Differently In Different People?
- Male MBC Treatment And Clinical Trials
- MBC and NED
2021
- Treatment Strategies for Triple-Positive MBC
- Lobular Metastatic Breast Cancer
- Theragnostics
- Health Insurance for MBC
- Immunotherapy Resistance
- Lymphodepletion in Cancer Immunotherapy
- Local Therapies for Liver Mets
- Side Effects of Radiation Therapy for Brain Mets
- Screening for Breast Cancer Brain Metastases
- What is Next-Generation Sequencing?
2020
2019
- Diagnosing & Treatment of Bone Metastases
- Genetic vs. Genomic Testing
- More Men Needed in Breast Cancer Trials
- Should You Get A Second Opinion?
- Treatment Guidelines for Metastatic Breast Cancer
- What to Know About Palliative Care for MBC
- Learn From Home With a Webinar
- What is CAR-T Cell Immunotherapy?
- Managing Lymphedema
SEARCH OUR SITE
for past articles or specific information.